Edition:
United Kingdom

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

743.35INR
22 Jun 2018
Change (% chg)

Rs6.90 (+0.94%)
Prev Close
Rs736.45
Open
Rs737.00
Day's High
Rs754.90
Day's Low
Rs734.15
Volume
419,456
Avg. Vol
729,159
52-wk High
Rs1,039.00
52-wk Low
Rs600.00

Select another date:

Fri, Feb 9 2018

BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Amantadine Hydrochloride Tablets​

* UNIT, JUBILANT PHARMA GETS ANDA FINAL APPROVAL FOR AMANTADINE HYDROCHLORIDE TABLETS, GENERIC VERSION OF SYMMETREL OF ENDO​ Source text: http://bit.ly/2EtLooJ Further company coverage:

BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Clonidine Hydrochloride Extended-Release Tablets‍​

* JUBILANT PHARMA GOT ANDA APPROVAL FOR CLONIDINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS‍​ Source text: http://bit.ly/2Gt6DoZ Further company coverage:

BRIEF-India's Jubilant Life Sciences Issues Commercial Papers Worth 900 Mln Rupees

* ISSUED COMMERCIAL PAPERS WORTH 900 MILLION RUPEES Source text - http://bit.ly/2mElAvi Further company coverage:

BRIEF-India's Jubilant Life Sciences Dec Qtr Consol Profit Up 78 Pct

* DEC QUARTER CONSOL NET PROFIT 2.13 BILLION RUPEES VERSUS PROFIT OF 1.19 BILLION RUPEES LAST YEAR

BRIEF-Jubilant Life Sciences Unit Gets sNDA Approval For New Indications From USFDA For Draximage DTPA

* SAYS UNIT GETS SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA Source text for Eikon: Further company coverage:

Select another date: